The immunotherapy used in the trial was nivolumab ( Opdivo ), a drug delivered intravenously that works by disabling a ...
The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...
7h
The Healthy on MSNWhat Is Allergy Immunotherapy, and Does It Work?More than 100 million Americans experience allergies to everyday exposures like pollen, mold and pet fur, according to data ...
In oncology, immunotherapy stands as a transformative approach for treating solid tumors, notably through pioneering treatments like immune checkpoint ...
A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed ...
This approach aims to improve treatment for patients with this highly aggressive and treatment-resistant type of breast ...
BofA has initiated coverage of Candel Therapeutics (NASDAQ:CADL) with a buy rating, citing the potential of its immunotherapy drug candidates CAN-2409 and CAN-3110. "While approved therapies may have ...
Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.
1d
StudyFinds on MSNPersonalized vaccines halt kidney cancer after encouraging phase 1 trialGroundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...
Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...
2d
Stockhead on MSNAdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creationAdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results